HempNewsBreaks

TuesdayOct 10, 2017 9:51 am

HempNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Addition of Dr. Mauro Maccarrone to Scientific Advisory Board

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the addition of Dr. Mauro Maccarrone to its scientific advisory board. Maccarrone is professor and chair of biochemistry and molecular biology at Campus Bio-Medico, University of Rome. He also serves as director of the Laboratory of Lipid Neurochemistry of the European Center for Brain Research-IRCCS Santa Lucia Foundation in Rome. “InMed is dedicated to developing industry-leading products in diseases with high unmet medical needs. One key element in drug development is to ensure that we are working with leading scientists in the field who can contribute their…

Continue Reading

MondayOct 09, 2017 12:16 pm

HempNewsBreaks – 22nd Century Group, Inc. (NYSE: XXII) Announces $54M Common Stock Only Registered Direct Offering

22nd Century Group (NYSE MKT: XXII) this morning said that it has entered into an agreement with institutional investors to collect approximately $54 million in gross proceeds in a registered direct offering from the sale of 20.57 million shares of common stock at a price of $2.625 per share. Total proceeds will raise the company’s cash balance to over $60 million, which covers all regular operating expenses for more than five years. Subject to customary closing conditions, the offering is anticipated to close on or about October 10, 2017. “More than $50 million in net proceeds will significantly improve our…

Continue Reading

FridayOct 06, 2017 12:17 pm

HempNewsBreaks – Algae Dynamics Corp. (ADYNF) Prepares for Increased Cannabis Demand in Canada

Algae Dynamics Corp. (OTC: ADYNF), a company engaged in developing unique health products and pharmaceuticals utilizing cannabis and algae oils, is well-positioned to benefit from the impending legalization of recreational marijuana in Canada, which the Canadian government is endeavoring to accomplish by mid-2018. The company’s focus on the development of proprietary research and products utilizing cannabis-derived botanical oils addresses two areas of key interest to consumers: the noted health benefits of cannabinoids and smoke-free alternatives for marijuana consumption. An article discussing this reads: “Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once…

Continue Reading

ThursdayOct 05, 2017 9:25 am

HempNewsBreaks – EVIO, Inc. (EVIO) Providing Accredited Testing Services to Oregon’s Industrial Hemp Sector

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that it is now prepared to offer accredited testing services to Oregon’s industrial hemp sector. “Industrial hemp is a rapidly growing industry with product applications ranging from foods like hemp seed, personal care products, textiles, and other industrial and consumer goods such as building materials,” Lori Glauser, COO of EVIO, stated in the news release. “In fact, hemp-based CBD oil alone is projected to reach $1 billion in sales by 2020, and, notably, big box stores like Target and Wal Mart are already offering the…

Continue Reading

WednesdayOct 04, 2017 10:32 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on In Vitro Data Related to IGC-AD1

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent. “Based on our analysis of this and other previously announced compelling data, we are readying IGC-AD1 in a liquid formulation that will not cause inebriation,” Ram Mukunda, CEO of IGC, stated in the news release. “The initial commercialization will be through licensed medical cannabis dispensaries.” As…

Continue Reading

WednesdayOct 04, 2017 10:05 am

HempNewsBreaks – PotNetwork Holding, Inc. (POTN) Names Dr. Richard Goulding as New Chief Executive Officer

PotNetwork Holding, Inc. (OTC: POTN) this morning announced, as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, its appointment of Richard Goulding, MD as its new chief executive officer. Per the news release, Goulding is expected to play a key role in directing PotNetwork’s endeavors to develop targeted formulas designed to deliver results for a diverse spectrum of challenges that can be aided by cannabidiol. “We believe, based on studies and reports, that CBD can contribute impressively to quality of life in those that are able to benefit from its…

Continue Reading

WednesdayOct 04, 2017 9:36 am

HempNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Enters Collaboration and Licensing Agreement with Canntab Therapeutics

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) yesterday announced its entry into a collaboration and licensing agreement with Canntab Therapeutics Limited, developer of a patent-pending oral sustained release formulation for cannabinoids. Per the terms of the agreement, Emblem and Canntab will collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of this sustained release product, with Emblem receiving the exclusive right in Canada to Canntab’s patents and know-how for the purpose of developing and commercializing the innovative product under the Emblem brand. Manufacture of the sustained release product is expected to be completed by Emblem or Canntab following…

Continue Reading

TuesdayOct 03, 2017 1:24 pm

HempNewsBreaks – DOJA Cannabis Company (CSE: DOJA) Expands Production Capacity with Building Acquisition in Kelowna

DOJA Cannabis Company (CSE: DOJA) this morning said the courts have approved its offer to acquire a 22,580 sq.ft. building in Kelowna, British Columbia, out of bankruptcy protection. The closing of the acquisition is anticipated to take place on October 27. The company is also building a new facility which, upon completion, will raise DOJA’s corporate cannabis production capacity to more than 5,000 kg per year. “The acquisition is a game changer for DOJA, it allows us to expand our production capacity by almost 8 times, diversify our strain production, integrate a world class extraction lab and leverage the economies…

Continue Reading

TuesdayOct 03, 2017 1:23 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action. Lexaria intends to out-license this patented and proprietary technology, and the company has already applied this delivery technology to its line of products, which includes ViPova, Lexaria Energy and TurboCBD. An article further discussing this reads: “Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of…

Continue Reading

TuesdayOct 03, 2017 1:21 pm

HempNewsBreaks – India Globalization Capital (NYSE: IGC) Demonstrates Potential in Alzheimer’s Treatment Market

In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed relief to Alzheimer’s sufferers. A recent IGC press release (http://cnw.fm/Cq71C) gave an update on in vitro data that has been compiled from genetically engineered cell lines in an Alzheimer’s disease model, demonstrating that, at varying THC concentrations, the aggregation of Aβ protein (the buildup of which has been linked to causing Alzheimer’s) decreases by up to 40 percent. An article further discussing this reads: “IGC…

Continue Reading